Trial
NCT04348071
Safety and Efficacy of Ruxolitinib for COVID-19
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Colorado, Denver
Collaborators
—
Condition
COVID-19
Intervention
Ruxolitinib
Why stopped
Could not make FDA required changes
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-08